Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cochlear
Sydney, New South Wales, Australiacochlear.com ↗
- Ownership
- Public · COH
- Employees
- ~5155
- Development stage
- Other
01
Overview
Cochlear is the global leader in implantable hearing solutions, with a portfolio that includes cochlear implants, bone conduction systems, and acoustic implants. The company’s products are widely used for various types of hearing loss and have received multiple regulatory approvals worldwide. Recent clinical milestones include FDA approval for expanding pediatric indications and next-generation sound processors[1][4].
- Therapeutic areas
- NeurologyOther
- Modalities
- DeviceNon-pharmacological therapy (implantable hearing solutions)
- Industry
- Implantable Medical Devices
02
Financials
- Market cap
- $541.4M
- Total revenue
- $0
- Enterprise value
- $780.9M
Beyond the preview
Go deeper on Cochlear.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cochlear.